1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INHIBIKASE THERAPEUTICS INC
Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

Read More
1.78 -0.06 (-3.26%)
57.62% Fall from 52W High
12,596
XNAS Volume

XNAS 29 Aug, 2025 11:51 AM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
10.2 / 100
Momentum Score
Technically Neutral
46.1 / 100
Analyst Price Target
No estimates available

9

S

11

W

5

O

0

T

SWOT Analysis

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..